193 related articles for article (PubMed ID: 9144449)
1. Production and characterization of specific antibodies: utilization to predict organ- and species-selective pneumotoxicity of 3-methylindole.
Kaster JK; Yost GS
Toxicol Appl Pharmacol; 1997 Apr; 143(2):324-37. PubMed ID: 9144449
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of 3-methylindole in human tissues.
Ruangyuttikarn W; Appleton ML; Yost GS
Drug Metab Dispos; 1991; 19(5):977-84. PubMed ID: 1686246
[TBL] [Abstract][Full Text] [Related]
3. Pathology and glutathione status in 3-methylindole-treated rodents.
Adams JD; Laegreid WW; Huijzer JC; Hayman C; Yost GS
Res Commun Chem Pathol Pharmacol; 1988 Jun; 60(3):323-36. PubMed ID: 3175331
[TBL] [Abstract][Full Text] [Related]
4. Metabolism and bioactivation of 3-methylindole by Clara cells, alveolar macrophages, and subcellular fractions from rabbit lungs.
Thornton-Manning JR; Nichols WK; Manning BW; Skiles GL; Yost GS
Toxicol Appl Pharmacol; 1993 Oct; 122(2):182-90. PubMed ID: 8212000
[TBL] [Abstract][Full Text] [Related]
5. Correlation between pulmonary cytochrome P450 transcripts and the organ-selective pneumotoxicity of 3-methylindole.
Ramakanth S; Thornton-Manning JR; Wang H; Maxwell H; Yost GS
Toxicol Lett; 1994 Mar; 71(1):77-85. PubMed ID: 8140592
[TBL] [Abstract][Full Text] [Related]
6. Adducts of 3-methylindole and glutathione: species differences in organ-selective bioactivation.
Nocerini MR; Carlson JR; Yost GS
Toxicol Lett; 1985 Nov; 28(2-3):79-87. PubMed ID: 4071564
[TBL] [Abstract][Full Text] [Related]
7. Electrophilic metabolites of 3-methylindole as toxic intermediates in pulmonary oedema.
Nocerini MR; Carlson JR; Yost GS
Xenobiotica; 1984 Jul; 14(7):561-4. PubMed ID: 6506769
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic studies on the cytochrome P450-catalyzed dehydrogenation of 3-methylindole.
Skiles GL; Yost GS
Chem Res Toxicol; 1996; 9(1):291-7. PubMed ID: 8924606
[TBL] [Abstract][Full Text] [Related]
9. The effect of 3-methylindole on superoxide and hydrogen peroxide production and NADPH oxidation by goat lung microsomes.
Laegreid WW; Breeze RG
Res Commun Chem Pathol Pharmacol; 1985 Mar; 47(3):387-97. PubMed ID: 2986255
[TBL] [Abstract][Full Text] [Related]
10. Effect of glutathione status on covalent binding and pneumotoxicity of 3-methylindole in goats.
Nocerini MR; Carlson JR; Breeze RG
Life Sci; 1983 Jan; 32(5):449-58. PubMed ID: 6823204
[TBL] [Abstract][Full Text] [Related]
11. Cloning and expression of CYP2F3, a cytochrome P450 that bioactivates the selective pneumotoxins 3-methylindole and naphthalene.
Wang H; Lanza DL; Yost GS
Arch Biochem Biophys; 1998 Jan; 349(2):329-40. PubMed ID: 9448722
[TBL] [Abstract][Full Text] [Related]
12. Dose response in 3-methylindole-induced bronchiolar epithelial necrosis in mice.
Turk MA; Flory W; Henk WG
Res Commun Chem Pathol Pharmacol; 1984 Dec; 46(3):351-62. PubMed ID: 6515126
[TBL] [Abstract][Full Text] [Related]
13. Induction of pulmonary edema and emphysema in goats by intraruminal administration of 3-methylindole.
Dickinson EO; Yokoyama MT; Carlson JR; Bradley BJ
Am J Vet Res; 1976 Jun; 37(6):667-72. PubMed ID: 937787
[TBL] [Abstract][Full Text] [Related]
14. Thioether adducts of a new imine reactive intermediate of the pneumotoxin 3-methylindole.
Skordos KW; Laycock JD; Yost GS
Chem Res Toxicol; 1998 Nov; 11(11):1326-31. PubMed ID: 9815193
[TBL] [Abstract][Full Text] [Related]
15. Potent mutagenicity of 3-methylindole requires pulmonary cytochrome P450-mediated bioactivation: a comparison to the prototype cigarette smoke mutagens B(a)P and NNK.
Weems JM; Lamb JG; D'Agostino J; Ding X; Yost GS
Chem Res Toxicol; 2010 Nov; 23(11):1682-90. PubMed ID: 20795680
[TBL] [Abstract][Full Text] [Related]
16. Organ-selective switching of 3-methylindole toxicity by glutathione depletion.
Yost GS; Kuntz DJ; McGill LD
Toxicol Appl Pharmacol; 1990 Mar; 103(1):40-51. PubMed ID: 2315931
[TBL] [Abstract][Full Text] [Related]
17. Evidence supporting the formation of 2,3-epoxy-3-methylindoline: a reactive intermediate of the pneumotoxin 3-methylindole.
Skordos KW; Skiles GL; Laycock JD; Lanza DL; Yost GS
Chem Res Toxicol; 1998 Jul; 11(7):741-9. PubMed ID: 9671536
[TBL] [Abstract][Full Text] [Related]
18. Glutathione adduct formation with microsomally activated metabolites of the pulmonary alkylating and cytotoxic agent, 3-methylindole.
Nocerini MR; Carlson JR; Yost GS
Toxicol Appl Pharmacol; 1985 Oct; 81(1):75-84. PubMed ID: 4049423
[TBL] [Abstract][Full Text] [Related]
19. Effect of 3-methylindole on the plasma and lung concentrations of prostaglandins and thromboxane B2 in goats.
Acton KS; Bray TM; Boermans HJ
Comp Biochem Physiol A Comp Physiol; 1989; 94(4):677-81. PubMed ID: 2575955
[TBL] [Abstract][Full Text] [Related]
20. The metabolic basis of 3-methylindole-induced pneumotoxicity.
Bray TM; Kirkland JB
Pharmacol Ther; 1990; 46(1):105-18. PubMed ID: 2181487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
